As the nation gears up for a massive vaccination effort, the Trump administration is doubling down on a novel, unproven injection device by providing more than half a billion dollars in government financing for something that is still awaiting Food and Drug Administration approval.
Later today, the U.S. International Development Finance Corp, or DFC, is expected to announce that it has extended a $590 million loan to ApiJect Systems America, NPR has learned. The Connecticut company makes a disposable injection device that it says can be mass produced to deliver vaccines and medications around the world.
The single-use, self-contained devices are designed to be an alternative to traditional vials and syringes. “This is going to be, we believe, the next generation of safe injections worldwide,” ApiJect Systems Corp. Executive Chairman Jay Walker told NPR.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
